Dodge & Cox recently announced the acquisition of new stake in Sanofi (NASDAQ:SNY). The institutional investor has increased its shareholding in the Healthcare company by 11.29% to 84.19 million shares with purchase of 8.54 million shares. This fresh investment now brings its stake to 3.34% valued currently at $3.94 billion. In addition, Boston Partners Global Investors, raised its holdings by 0.52 million to 18.25 million shares. And Fidelity Management & Research Co has lifted its position by 6.09% or 0.64 million shares – to 11.13 million shares.
With over 2.22 million Sanofi (SNY) shares trading Tuesday and a closing price of $47.86 on the day, the dollar volume was approximately $106.24 million. The shares have shown a positive half year performance of 15.35% and its price on 03/14/23 gained nearly 1.76%. Currently, there are 2.51B common shares owned by the public and among those 2.24B shares have been available to trade.
Do You Know The Best Place To Find Gains In Volatile Markets?
In today's chaotic marketplace, the biggest gains will come from some currently-small companies that pass by older, larger businesses still stuck in a pre-pandemic world. The trick is figuring out which small caps will be tomorrow's winners. That's why StockWire News has put together a special Wealth Building Report, highlighting 3 small cap stocks set to soar in 2023.
Click here for full details and to join for free.
Sponsored
An analysis of what Wall Street brokers have to say about the expected price targets for this stock gives us this picture: 23 analysts who have offered their price forecasts for SNY have a consensus price objective of $56.55. The analysts have set the share’s price value over the next 12 months at a high of $64.39 and a low of $45.42. The average price target is 24.63% above its recent price level and a downside to the estimated low will see the stock lose -5.37% over that period. But an upside of 25.67% will see the stock hit the forecast high price target while median target price for the stock is $56.11.
The top 3 mutual fund holders in Sanofi are Dodge & Cox Stock Fund, Dodge & Cox Balanced Fund, and John Hancock III – Disciplined Va. Dodge & Cox Stock Fund owns 59.88 million shares of the company’s stock, all valued at over $2.81 billion. The company bought an additional 6.36 million shares recently to bring their total holdings to about 2.37% of the shares outstanding. Dodge & Cox Balanced Fund bought 1.45 million shares to see its total holdings expand to 6.84 million shares valued at over $320.62 million and representing 0.27% of the shares outstanding. John Hancock III – Disciplined Va now owns shares totaling to 0.26% of the shares outstanding.
Shares of Sanofi (NASDAQ: SNY) opened at $47.55, up $0.52 from a prior closing price of $47.03. However, the script later moved the day high at 47.90, up 1.76%. The company’s stock has a 5-day price change of 0.63% and 3.46% over the past three months. SNY shares are trading -1.18% year to date (YTD), with the 12-month market performance down to -5.12% lower. It has a 12-month low price of $36.91 and touched a high of $57.79 over the same period. SNY has an average intraday trading volume of 1.95 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by 0.82%, -0.35%, and 3.80% respectively.
Institutional ownership of Sanofi (NASDAQ: SNY) shares accounts for 10.30% of the company’s 2.51B shares outstanding. Mutual fund holders own 4.76%, while other institutional holders and individual stakeholders account for 5.51% and — respectively.
It has a market capitalization of $120.95B and a beta (3y monthly) value of 0.54. The stock’s trailing 12-month PE ratio is 13.59, while the earnings-per-share (ttm) stands at $3.52. The company has a PEG of 1.10 and a Quick Ratio of 1.00 with the debt-to-equity ratio at 0.29. Price movements for the stock have been influenced by the stock’s volatility, which stands at 1.49% over the week and 1.25% over the month.
Analysts forecast that Sanofi (SNY) will achieve an EPS of $Signature Bank for the current quarter, $70.00 for the next quarter and $Stocks for Type. The lowest estimate earnings-per-share for the quarter is $Polestar Automotive Holding UK while analysts give the company a high EPS estimate of $Synovus Financial Corp. Comparatively, EPS for the current quarter was $Sony Group Corporation a year ago. Earnings per share for the fiscal year are expected to increase by 34.60%, and 11.90% over the next financial year. EPS should shrink at an annualized rate of 12.30% over the next five years, compared to 17.50% over the past 5-year period.
If you are looking to buy this stock, then you may note that the average analyst recommendation by 23 brokerage firm advisors rate Sanofi (SNY) as a “Strong Buy” at a consensus score of 1.50. Specifically, 13 Wall Street analysts polled rate the stock as a buy, while 8 of the 23 advise that investors “hold,” and 0 rated it as a “Sell.”
SVB Leerink on their part issued Outperform rating on September 27, 2021.
